Chemcon Speciality Chemicals Ltd

Chemcon Speciality Chemicals Ltd has issued a notice for its 37th Annual General Meeting (AGM) to be held on Thursday, September 17, 2026, at 11:30 am IST. The meeting will be conducted entirely through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) without physical presence. Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the re-appointment of a director retiring by rotation, and the ratification of remuneration for the Cost Auditors for the fiscal year ending March 31, 2027. The notice also clarifies that proxy appointments are not permitted for this AGM.

Chemcon Speciality Chemicals Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report, which forms an integral part of the company's Annual Report for FY25-26, details corporate identity, business activities, operations, and employee information. The company's primary business activity is the manufacturing of organic and inorganic chemicals, accounting for 94% of its turnover, with Hexamethyl Disilazane (HMDS) and other bromides being key products. Exports contribute 41% to the total turnover. The report also outlines employee demographics, including a small percentage of differently-abled employees and a low representation of women in key management positions.

Chemcon Speciality Chemicals Ltd has released its Annual Report for FY2025-26. The company reported a revenue from operations of ₹240.0 crore, a 15.7% increase from the previous year's ₹207.4 crore. This growth was driven by improved demand, better customer engagement, and favorable product realisations. However, increased raw material costs impacted margins, leading to an EBITDA of ₹30.2 crore and a Profit After Tax (PAT) of ₹23.6 crore, which represents a decline of 8.2% and 3.7% respectively compared to the prior year. The company also made progress in integrating the acquired Shivam Petrochem Industries business, which is expected to contribute to future revenues.

Chemcon Speciality Chemicals Limited has announced that its 37th Annual General Meeting (AGM) will be conducted on Thursday, September 17, 2026, at 11:30 a.m. IST. The meeting will be held virtually via Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in adherence to Ministry of Corporate Affairs and SEBI guidelines. The company has set Thursday, September 10, 2026, as the cut-off date to determine which shareholders are eligible to attend the AGM and cast their votes electronically. This information is also available on the company's website.

Chemcon Speciality Chemicals Limited has announced its unaudited financial results for the first quarter ended June 30, 2026. The results were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) and reviewed by Shah Mehta & Bakshi Chartered Accountants. The company's board of directors has approved the statement. The review report indicates no material misstatements and compliance with SEBI regulations.

Chemcon Speciality Chemicals reported standalone revenue of ₹66.49 Cr for Q1 FY27 (quarter ended June 30, 2026), up 24.2% year-on-year from ₹53.52 Cr, with net profit up 71.6% YoY to ₹10.96 Cr from ₹6.39 Cr. Basic EPS rose to ₹2.99 from ₹1.74 a year ago. Sequentially, revenue was down 11.9% from ₹75.42 Cr in Q4 FY26 (audited), even though PAT rose 72.1% QoQ from ₹6.37 Cr — the sequential profit jump is a margin recovery off a weak Q4 base, not a sign of stronger sequential volumes, and should not be read as the headline story. The margin move is the real story: operating margin (EBITDA/revenue) expanded to 23.2% from 14.5% a year ago and 11.8% in Q4 FY26, while net margin (PAT/total income) rose to 15.6% from 11.2% YoY and 8.0% in Q4 FY26. Two things drove it — combined material-related costs (cost of materials, traded-goods purchases, net of inventory movement) fell to 55.5% of revenue from 58.8% YoY, and other expenses fell to 12.7% of revenue from 17.4% YoY, pointing to genuine operating leverage on the cost side. Part of the material-cost relief, however, rides on an unusually large inventory build this quarter (-₹7.61 Cr in the 'changes in inventories' line versus +₹1.95 Cr a year ago) — a working-capital swing that reduced reported cost of goods sold and may not repeat, so the quality of this quarter's margin print is not fully clean. Finance costs rose to ₹0.85 Cr from ₹0.34 Cr and depreciation to ₹3.75 Cr from ₹2.72 Cr, consistent with ongoing capacity-related capex; effective tax rate was 24.7%, broadly flat versus 24.2% a year ago. No consensus/street estimates for this quarter could be located for this small-cap name, so vs-street stands unknown rather than assumed; similarly, the company has no formal prior guidance on record in our data or via web search, so vs-guidance is unknown rather than inferred. There is no management press release or concall commentary available yet to cross-check management's own framing of the quarter. This is a standalone-only filing — the company confirms it has no subsidiary, associate or joint venture as of June 30, 2026 — so there is no consolidated number to reconcile against. The quarter's other board actions (AGM notice for September 17, 2026, directors' report for FY26, auditor reappointment, and the trading-window closure ahead of results) are administrative and unrelated to the operating numbers. Going into Q2 FY27, the key test is whether the OPM print holds above 20% once the inventory swing normalizes, or reverts toward the 11-15% band the company ran at through FY26 — that will tell whether this quarter's cost efficiency is structural or a one-quarter working-capital effect.

Chemcon Speciality Chemicals Ltd has announced a Board of Directors meeting scheduled for August 3, 2026. The primary agenda items include the consideration and approval of the Unaudited Financial Results for the quarter ended June 30, 2026, the Directors' Report for the financial year ended March 31, 2026, and the Notice for the 37th Annual General Meeting. Concurrently, the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, until 48 hours after the announcement of the Q1 FY27 financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Chemcon Speciality Chemicals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from July 1st, 2026, and will remain in effect until 48 hours after the announcement of the company's unaudited financial results for the quarter ended June 30th, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing insider trading.

Chemcon Speciality Chemicals Ltd's Board of Directors, in its meeting on May 21, 2026, approved the reappointment of M/s Chetan Gandhi & Associates as Cost Auditor and M/s Kulin Shah & Associates as Internal Auditors for the financial year 2026-27. The board also approved the audited financial statements and results for the year ended March 31, 2026, and declared an interim dividend of ₹6.50 per share. The record date for the dividend is May 28, 2026.

Chemcon Speciality Chemicals Ltd's board approved the audited financial statements and results for the year ended March 31, 2026. They also approved a first interim dividend of ₹6.50 per share (65% of face value) for FY 2025-26, with a record date of May 28, 2026. The board re-appointed M/s Chetan Gandhi & Associates as Cost Auditor and M/s Kulin Shah & Associates as Internal Auditors for FY 2026-27.